Home > Resources > Whitepapers > Live-Cell Analysis of Cell Subsets and Heterogeneity

Live-Cell Analysis of Cell Subsets and Heterogeneity

July 30, 2018

Considerable heterogeneity exists in the properties and activity of individual cells, even in the simplest cell system. Analysis at the cell-by-cell level promises valuable and additional biological insight beyond which whole population measures may deliver. In this article, we consider this opportunity from a perspective of analyzing living cells over time, and describe new, enabling and industrial-scale, live-cell analysis solutions for quantifying the phenotypic biology of cell subsets in heterogeneous cultures.

Spotlight

Capstone Treatment Center

Founded in 2001, Capstone Treatment Center is a licensed residential treatment center for young men struggling with addictions, trauma, mental health, and other issues. Our clients come from all over the United States and other countries to find a safe, professional, and Christ-centered environment at Capstone to begin their recovery journey.

OTHER WHITEPAPERS

Biosimilars – commercial best practices in the age of sustainability

whitePaper | November 4, 2019

Revenues from biologics increased by 70% from 2011 to 2016. Biologics account for 20-22% of total pharmaceutical spending. IQVIA estimates US biologics spending will reach $320bn by 2023

Pioneering Cell and Gene Therapy Solutions From Discovery to the Clinic

whitePaper | April 14, 2020

Your vision is to create revolutionary cell and gene therapies to treat life threatening diseases. Bio-Techne and its family of brands is on this journey with you. As a full-solution ancillary reagent and services provider, we will stand by you, providing flexible and pioneering tools to simplify your workflow. From CAR T cells to pluripotent stem cells, let us help you get your therapy to the patients that need it

Synthetic Biology Biotechnology and AgTech

whitePaper | March 12, 2022

CRISPR, gene editing, biotech, precision agriculture and automation influencing the future of business, government, food, medicine, geopolitics and society

Small Molecule Apis Made with Compelling Science

whitePaper | July 17, 2023

As your API demand grows, we grow with you. While we can manufacture volumes in metric tons, we can also go small. If you have a chemistry-based compound and need smaller batches for clinical or commercial use, we can offer the quantities you need at our cGMP small-scale/pilot facilities until you’re ready for full-scale manufacturing.